Improving early detection and determining best treatments for people with cerebral palsy


The Australasian Cerebral Palsy Clinical Trials Network (AusCP-CTN) is a Centre for Research Excellence (CRE) funded by the National Health and Medical Research Council (NHMRC; $2.49m over 5 years).  The AusCP-CTN CRE has a work plan to uplift earlier detection of cerebral palsy, fast track children to multi-site randomised clinical trials of new neuroprotectants and to develop and test new rehabilitation. Knowledge translation studies will ensure effective transfer to enhanced clinical practice. The CRE will overcome known barriers to implementation, developing international clinical practice guidelines guided by a consumer network. The changes in outcomes of children with CP due to the new clinical trials will be tested in Australian Cerebral Palsy Register (ACPR).

Our future vision is one of a continuing decline in the rate of cerebral palsy and an improvement in health outcomes as children with CP become more contributing members of society.

Subscribe to our newsletter

Our partners

Our centre is proud to partner with many organisations in undertaking our 5-year research program. The Centre for Research Excellence: Australasian Cerebral Palsy Clinical Trials Network (AusCP-CTN) combines leading research centres from throughout Australia and New Zealand. Together, we will conduct world standard, multisite, clinical trials to improve early detection and determine the best interventions and treatments for children with cerebral palsy.